<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD006882" GROUP_ID="LIVER" ID="343507020212350402" MERGED_FROM="" MODIFIED="2010-12-07 09:37:08 +0100" MODIFIED_BY="Dimitrinka Nikolova" REVIEW_NO="30" REVMAN_SUB_VERSION="5.0.25" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="3.0">
<COVER_SHEET MODIFIED="2010-12-07 09:08:25 +0100" MODIFIED_BY="Dimitrinka Nikolova">
<TITLE>Three dimensional versus two dimensional imaging for laparoscopic cholecystectomy</TITLE>
<CONTACT>
<PERSON ID="EDD1B9F582E26AA20135ECF1AB0B3200" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Kurinchi Selvan</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Gurusamy</LAST_NAME>
<SUFFIX>MBBS MS MRCS</SUFFIX>
<POSITION>Clinical Research Fellow</POSITION>
<EMAIL_1>kurinchi2k@hotmail.com</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE>+44 (0)7944 629303</MOBILE_PHONE>
<ADDRESS>
<DEPARTMENT>Department of Surgery</DEPARTMENT>
<ORGANISATION>Royal Free Campus, UCL Medical School</ORGANISATION>
<ADDRESS_1>9th Floor, Royal Free Hospital</ADDRESS_1>
<ADDRESS_2>Pond Street</ADDRESS_2>
<CITY>London</CITY>
<ZIP>NW3 2QG</ZIP>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>+44 207 830 2757</PHONE_1>
<PHONE_2/>
<FAX_1>+44 207 830 2688</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CONTACT>
<CREATORS MODIFIED="2010-12-07 09:08:25 +0100" MODIFIED_BY="Dimitrinka Nikolova">
<PERSON ID="EDD1B9F582E26AA20135ECF1AB0B3200" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Kurinchi Selvan</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Gurusamy</LAST_NAME>
<SUFFIX>MBBS MS MRCS</SUFFIX>
<POSITION>Clinical Research Fellow</POSITION>
<EMAIL_1>kurinchi2k@hotmail.com</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE>+44 (0)7944 629303</MOBILE_PHONE>
<ADDRESS>
<DEPARTMENT>Department of Surgery</DEPARTMENT>
<ORGANISATION>Royal Free Campus, UCL Medical School</ORGANISATION>
<ADDRESS_1>9th Floor, Royal Free Hospital</ADDRESS_1>
<ADDRESS_2>Pond Street</ADDRESS_2>
<CITY>London</CITY>
<ZIP>NW3 2QG</ZIP>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>+44 207 830 2757</PHONE_1>
<PHONE_2/>
<FAX_1>+44 207 830 2688</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="37894543395843023597100607110408" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Samir</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Sahay</LAST_NAME>
<SUFFIX/>
<POSITION>Clinical Fellow</POSITION>
<EMAIL_1>drsamirsahay@gmail.com</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE>+44 754 597 6842</MOBILE_PHONE>
<ADDRESS>
<DEPARTMENT>Department of Surgery</DEPARTMENT>
<ORGANISATION>Royal Free Hampstead NHS Foundation Trust</ORGANISATION>
<ADDRESS_1>Pond Street</ADDRESS_1>
<ADDRESS_2>Hampstead</ADDRESS_2>
<CITY>London</CITY>
<ZIP>NW3 2QG</ZIP>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>+44 207 830 2757</PHONE_1>
<PHONE_2/>
<FAX_1>+44 207 830 2688</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="0BFE5DB682E26AA200426E053932D8DE" ROLE="AUTHOR">
<PREFIX>Prof</PREFIX>
<FIRST_NAME>Brian</FIRST_NAME>
<MIDDLE_INITIALS>R</MIDDLE_INITIALS>
<LAST_NAME>Davidson</LAST_NAME>
<SUFFIX/>
<POSITION>Professor of HPB and Liver Transplant Surgery</POSITION>
<EMAIL_1>b.davidson@medsch.ucl.ac.uk</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>University Department of Surgery</DEPARTMENT>
<ORGANISATION>Royal Free Hospital and University College School of Medicine</ORGANISATION>
<ADDRESS_1>Pond Street</ADDRESS_1>
<ADDRESS_2/>
<CITY>London</CITY>
<ZIP>NW3 2QG</ZIP>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>+44 207 830 2757</PHONE_1>
<PHONE_2/>
<FAX_1>+44 207 830 2688</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CREATORS>
<DATES MODIFIED="2010-11-05 17:10:48 +0100" MODIFIED_BY="Dimitrinka Nikolova">
<UP_TO_DATE>
<DATE DAY="11" MONTH="10" YEAR="2010"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="11" MONTH="10" YEAR="2010"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="22" MONTH="11" YEAR="2012"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="1" YEAR="2008"/>
<REVIEW_PUBLISHED ISSUE="" YEAR=""/>
<LAST_CITATION_ISSUE ISSUE="1" YEAR="2008"/>
</DATES>
<WHATS_NEW MODIFIED="2010-06-21 13:23:52 +0200" MODIFIED_BY="Dimitrinka Nikolova"/>
<HISTORY/>
<SOURCES_OF_SUPPORT MODIFIED="2010-05-22 18:31:26 +0200" MODIFIED_BY="Kurinchi S Gurusamy">
<INTERNAL_SOURCES MODIFIED="2010-05-22 18:31:16 +0200" MODIFIED_BY="Kurinchi S Gurusamy">
<SOURCE MODIFIED="2010-05-22 18:31:16 +0200" MODIFIED_BY="Kurinchi S Gurusamy">
<NAME>None</NAME>
<COUNTRY CODE="NONE">Not specified</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES MODIFIED="2010-05-22 18:31:26 +0200" MODIFIED_BY="Kurinchi S Gurusamy">
<SOURCE MODIFIED="2010-05-22 18:31:26 +0200" MODIFIED_BY="Kurinchi S Gurusamy">
<NAME>None</NAME>
<COUNTRY CODE="NONE">Not specified</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2010-12-07 09:22:52 +0100" MODIFIED_BY="Dimitrinka Nikolova">
<SUMMARY MODIFIED="2010-12-06 16:38:07 +0100" MODIFIED_BY="Dimitrinka Nikolova">
<TITLE MODIFIED="2010-07-09 12:31:14 +0200" MODIFIED_BY="Dimitrinka Nikolova">Three dimensional imaging (3D) compared with two dimensional (2D) imaging for key hole removal of gallbladder</TITLE>
<SUMMARY_BODY MODIFIED="2010-12-06 16:38:07 +0100" MODIFIED_BY="Dimitrinka Nikolova">
<P>The benefits and harms of three dimensional imaging (3D) versus traditional two dimensional (2D) imaging for key hole removal of the gallbladder (laparoscopic cholecystectomy) is not known. We set out to assess the benefits and harms of use of three dimensional systems versus two dimensional systems during laparoscopic cholecystectomy. We searched various medical databases and trials registers until October 2010 for identifying randomised clinical trials irrespective of language, blinding, or publication status.</P>
<P>Two authors independently identified trials and independently extracted data. We performed all the analysis based on intention-to-treat analysis. One trial randomised 60 patients to three dimensional laparoscopic cholecystectomy (n = 30) compared with standard two dimensional laparoscopic cholecystectomy (n = 30). The report on the trial design revealed high risk of systematic error ('bias'). There were no post-operative complications or conversion to open cholecystectomy in either group. There was no difference in the operating time or number of surgical errors between the two groups. Currently, there is no evidence that three dimensional image is superior to two dimensional image in laparoscopic cholecystectomy. Further randomised clinical trials with low risk of systematic errors and random errors are necessary to assess the new systems of three dimensional imaging in comparison with two dimensional imaging.  </P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2010-12-06 16:04:25 +0100" MODIFIED_BY="Dimitrinka Nikolova">
<ABS_BACKGROUND MODIFIED="2010-07-09 11:34:04 +0200" MODIFIED_BY="Kurinchi S Gurusamy">
<P>The benefits and harms of three dimensional imaging versus traditional two dimensional imaging for laparoscopic cholecystectomy are not known.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2010-05-22 07:25:00 +0200" MODIFIED_BY="Kurinchi S Gurusamy">
<P>To assess the benefits and harms of use of three dimensional systems versus two dimensional systems during laparoscopic cholecystectomy.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2010-12-06 16:04:09 +0100" MODIFIED_BY="Dimitrinka Nikolova">
<P>We searched <I>The Cochrane Hepato-Biliary Group Controlled Trials Register</I>, the <I>Cochrane Central Register of Controlled Trials</I> (<I>CENTRAL</I>) in <I>The Cochrane Library</I>, <I>MEDLINE</I>, <I>EMBASE</I>, and <I>Science Citation Index Expanded</I> until October 2010 for randomised clinical trials.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2010-05-22 07:28:41 +0200" MODIFIED_BY="Kurinchi S Gurusamy">
<P>Only randomised clinical trials, irrespective of language, blinding, or publication status were considered for the review.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2010-07-09 11:34:04 +0200" MODIFIED_BY="Kurinchi S Gurusamy">
<P>Two authors independently identified trials and independently extracted data. We intended to calculate the risk ratio (RR), mean difference (MD), or standardised mean difference (SMD) with 95% confidence intervals (CI) using both the fixed-effect and the random-effects models with RevMan 5 based on intention-to-treat analysis.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2010-12-06 16:04:25 +0100" MODIFIED_BY="Dimitrinka Nikolova">
<P>One trial randomised 60 patients to three dimensional laparoscopic cholecystectomy (n = 30) versus standard two dimensional laparoscopic cholecystectomy (n = 30). This trial was of high risk of bias. There were no post-operative complications or conversion to open cholecystectomy in either group. There was no significant difference in the operating time (MD -1.00 minute; 95% CI -17.77 to 15.77) or number of errors between the two groups.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2010-05-22 18:35:12 +0200" MODIFIED_BY="Kurinchi S Gurusamy">
<P>Currently, there is no evidence that three dimensional image is superior to two dimensional image in laparoscopic cholecystectomy.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2010-12-07 09:22:52 +0100" MODIFIED_BY="Dimitrinka Nikolova">
<BACKGROUND MODIFIED="2010-12-06 16:38:07 +0100" MODIFIED_BY="Dimitrinka Nikolova">
<CONDITION MODIFIED="2010-12-06 16:38:07 +0100" MODIFIED_BY="Dimitrinka Nikolova">
<P>About 10% to 15% of the adult western population have gallstones (<LINK REF="REF-J_x00f8_rgensen-1987" TYPE="REFERENCE">Jørgensen 1987</LINK>; <LINK REF="REF-Muhrbeck-1995" TYPE="REFERENCE">Muhrbeck 1995</LINK>; <LINK REF="REF-Halldestam-2004" TYPE="REFERENCE">Halldestam 2004</LINK>). Between 1% and 4% become symptomatic in a year (<LINK REF="REF-Halldestam-2004" TYPE="REFERENCE">Halldestam 2004</LINK>). More than 50,000 cholecystectomies are performed per year in the United Kingdom alone (<LINK REF="REF-HES-2005" TYPE="REFERENCE">HES 2005</LINK>). Regional differences exist in the cholecystectomy rates (<LINK REF="REF-Mj_x00e4_land-1998" TYPE="REFERENCE">Mjäland 1998</LINK>). Laparoscopic cholecystectomy is now the preferred method of cholecystectomy (<LINK REF="REF-Fullarton-1994" TYPE="REFERENCE">Fullarton 1994</LINK>; <LINK REF="REF-Bakken-2004" TYPE="REFERENCE">Bakken 2004</LINK>; <LINK REF="REF-Keus-2006" TYPE="REFERENCE">Keus 2006</LINK>; <LINK REF="REF-Keus-2010" TYPE="REFERENCE">Keus 2010</LINK>).</P>
<P>In traditional laparoscopic cholecystectomy, the images used by the operating surgeon are two dimensional resulting in lack of depth perception in laparoscopic cholecystectomy. The surgeon has to mentally transform the two dimensional image into a three dimensional image using motion parallax through movement of the laparoscope, relative position of instruments, and shading of light and dark (<LINK REF="REF-Byrn-2007" TYPE="REFERENCE">Byrn 2007</LINK>). This may involve intense perceptual and mental processing throughout the operation (<LINK REF="REF-Hanna-1998" TYPE="REFERENCE">Hanna 1998</LINK>). </P>
</CONDITION>
<INTERVENTION MODIFIED="2010-12-06 16:38:07 +0100" MODIFIED_BY="Dimitrinka Nikolova">
<P>Two dimensional imaging is the method used in most laparoscopic centres for performing laparoscopic cholecystectomy. Three dimensional imaging has been suggested as an alternative to two dimensional imaging to overcome the difficulty due to lack of depth perception. Previously, the three dimensional effect was achieved by presenting two slightly different images in an alternating sequence to each of the eyes separated by a few milliseconds (<LINK REF="REF-Hanna-1998" TYPE="REFERENCE">Hanna 1998</LINK>). However, the current three dimensional systems have two separate optical channels and light sources. The right and left eyes receive unique images from each camera (<LINK REF="REF-Byrn-2007" TYPE="REFERENCE">Byrn 2007</LINK>). Thus, the imaging in the latest systems are similar to stereoscopic vision, in which the depth perception is achieved because of the subtle differences in the images received by each eye (<LINK REF="REF-Parker-2007" TYPE="REFERENCE">Parker 2007</LINK>).</P>
</INTERVENTION>
<THEORY MODIFIED="2010-12-06 16:38:07 +0100" MODIFIED_BY="Dimitrinka Nikolova">
<P>Three dimensional imaging may work by removing the necessity for the surgeon to mentally transform the two dimensional image into a three dimensional image using motion parallax through movement of the laparoscope, relative position of instruments, and shading of light and dark (<LINK REF="REF-Byrn-2007" TYPE="REFERENCE">Byrn 2007</LINK>). This improvement in the imaging technique may improve the information provided to the surgeons and may avoid the need to convert to open cholecystectomy. Laparoscopic cholecystectomy is usually converted to open cholecystectomy due to lack of sufficient information and due to any inadvertent injuries to important structures in the abdomen.</P>
</THEORY>
<IMPORTANCE MODIFIED="2010-05-22 08:00:51 +0200" MODIFIED_BY="Kurinchi S Gurusamy">
<P>We were not able to identify any systematic review assessing the benefits and harms of use of three dimensional systems versus two dimensional systems during laparoscopic cholecystectomy.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES>
<P>To assess the benefits and harms of use of three dimensional systems versus two dimensional systems during laparoscopic cholecystectomy.</P>
</OBJECTIVES>
<METHODS MODIFIED="2010-12-07 09:04:55 +0100" MODIFIED_BY="Dimitrinka Nikolova">
<SELECTION_CRITERIA MODIFIED="2010-12-06 16:38:07 +0100" MODIFIED_BY="Dimitrinka Nikolova">
<CRIT_STUDIES MODIFIED="2010-07-09 11:34:05 +0200" MODIFIED_BY="Kurinchi S Gurusamy">
<P>We considered only randomised clinical trials (irrespective of language, blinding, publication status, or sample size) for this review.</P>
<P>Quasi-randomised studies (where the method of allocating participants to a treatment are not strictly random, for example, date of birth, hospital record number, alternation) were excluded regarding assessment of benefit but would have been included regarding assessment of harms, if identified. </P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2010-07-09 11:34:05 +0200" MODIFIED_BY="Kurinchi S Gurusamy">
<P>Patients who were about to undergo laparoscopic cholecystectomy irrespective of age, elective or emergency laparoscopic cholecystectomy, and the reason why the laparoscopic cholecystectomy is performed.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2010-07-09 11:34:05 +0200" MODIFIED_BY="Kurinchi S Gurusamy">
<P>We included trials comparing three dimensional imaging versus the traditional two dimensional imaging in patients undergoing laparoscopic cholecystectomy, irrespective of whether human or robotic assistants were used.</P>
<P>Co-interventions were allowed if carried out equally in the trial intervention groups.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2010-12-06 16:38:07 +0100" MODIFIED_BY="Dimitrinka Nikolova">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2010-12-06 16:38:07 +0100" MODIFIED_BY="Dimitrinka Nikolova">
<OL>
<LI>Mortality.</LI>
<LI>Adverse events (bile duct injury, bile leak requiring endoscopic retrograde cholangiopancreatography, intra-abdominal collections requiring intervention, infected intra-abdominal collections, wound infection) as reported by the authors.</LI>
<LI>Quality of life.</LI>
</OL>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2010-05-22 10:11:20 +0200" MODIFIED_BY="Kurinchi S Gurusamy">
<OL>
<LI>Conversion to open cholecystectomy.</LI>
<LI>Operating time.</LI>
<LI>Errors (however defined by authors).</LI>
<LI>Surgeons' satisfaction (however defined by authors).</LI>
</OL>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2010-12-06 16:38:07 +0100" MODIFIED_BY="Dimitrinka Nikolova">
<ELECTRONIC_SEARCHES MODIFIED="2010-05-22 08:01:44 +0200" MODIFIED_BY="Kurinchi S Gurusamy">
<P>We searched <I>The Cochrane Hepato-Biliary Group Controlled Trials Register </I>(<LINK REF="REF-Gluud-2010" TYPE="REFERENCE">Gluud 2010</LINK>), the <I>Cochrane Central Register of Controlled Trials</I> (CENTRAL) in <I>The Cochrane Library</I>, <I>MEDLINE</I>, <I>EMBASE</I>, and <I>Science Citation Index Expanded</I> (<LINK REF="REF-Royle-2003" TYPE="REFERENCE">Royle 2003</LINK>). We have given the search strategies in <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK> with the time span for the searches.</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2010-12-06 16:38:07 +0100" MODIFIED_BY="Dimitrinka Nikolova">
<P>We searched the references of the identified trial to identify further relevant trials. We also searched the meta-register of controlled trials (mRCT) to identify further trials. The meta-register of controlled trials includes various trial registers including ISRCTN register and National Insititute of Health (NIH) trials registers (www.controlled-trials.com/mrct).</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2010-12-07 09:04:55 +0100" MODIFIED_BY="Dimitrinka Nikolova">
<STUDY_SELECTION MODIFIED="2010-05-22 08:21:08 +0200" MODIFIED_BY="Kurinchi S Gurusamy">
<P>Two authors (KG and SS) identified the trials for inclusion independently of each other. We planned to list the excluded studies with the reasons for the exclusion. Any differences were resolved through discussion.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2010-12-03 11:05:07 +0100" MODIFIED_BY="Dimitrinka Nikolova">
<P>Two authors (KG and SS) extracted the following data independently:</P>
<OL>
<LI>Year and language of publication.</LI>
<LI>Country.</LI>
<LI>Year of publication of the trial.</LI>
<LI>Inclusion and exclusion criteria.</LI>
<LI>Name of the three dimensional and two dimensional system used.</LI>
<LI>Elective surgery or acute cholecystitis.</LI>
<LI>Outcomes (mentioned above).</LI>
<LI>Risk of bias (described below).</LI>
</OL>
<P>We sought any unclear or missing information from the authors of the included trial. No reply was received. If there were more trials to be included, and in case there was any doubt on whether these trials shared the same patients - completely or partially (by identifying common authors and centres) - we planned to contact their authors in order to clarify whether the trial reports had been duplicated.</P>
<P>We resolved any differences in opinion through discussion.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2010-12-06 16:09:20 +0100" MODIFIED_BY="Dimitrinka Nikolova">
<P>We followed the instructions given in the <I>Cochrane Handbook for Systematic Reviews of Intervention</I> (<LINK REF="REF-Higgins-2009" TYPE="REFERENCE">Higgins 2009</LINK>) and the <I>Cochrane Hepato-Biliary Group Module</I> (<LINK REF="REF-Gluud-2010" TYPE="REFERENCE">Gluud 2010</LINK>). Methodological quality was defined as the confidence that the design and the report of the randomised clinical trial would restrict bias in the comparison of the intervention (<LINK REF="REF-Moher-1998" TYPE="REFERENCE">Moher 1998</LINK>). According to empirical evidence (<LINK REF="REF-Schulz-1995" TYPE="REFERENCE">Schulz 1995</LINK>; <LINK REF="REF-Moher-1998" TYPE="REFERENCE">Moher 1998</LINK>; <LINK REF="REF-Kjaergard-2001" TYPE="REFERENCE">Kjaergard 2001</LINK>; <LINK REF="REF-Wood-2008" TYPE="REFERENCE">Wood 2008</LINK>), the risk of bias of the trials was assessed based on the following bias risk domains:</P>
<SUBSECTION>
<HEADING LEVEL="4">Sequence generation</HEADING>
<UL>
<LI>Low risk of bias (the methods used is either adequate (eg, computer generated random numbers, table of random numbers) or unlikely to introduce confounding).</LI>
<LI>Uncertain risk of bias ( there is insufficient information to assess whether the method used is likely to introduce confounding).</LI>
<LI>High risk of bias (the method used (eg, quasi-randomised studies) is improper and likely to introduce confounding).</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Allocation concealment</HEADING>
<UL>
<LI>Low risk of bias (the method used (eg, central allocation) is unlikely to induce bias on the final observed effect).</LI>
<LI>Uncertain risk of bias (there is insufficient information to assess whether the method used is likely to induce bias on the estimate of effect).</LI>
<LI>High risk of bias (the method used (eg, open random allocation schedule) is likely to induce bias on the final observed effect).</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Blinding of participants, personnel, and outcome assessors</HEADING>
<P>It is impossible to blind the surgeons to the groups. Blinding of patients can be achieved easily and blinding of outcomes assessors can also be achieved if sufficient efforts were made.</P>
<UL>
<LI>Low risk of bias (blinding was performed adequately, or the outcome measurement is not likely to be influenced by lack of blinding).</LI>
<LI>Uncertain risk of bias (there is insufficient information to assess whether the type of blinding used is likely to induce bias on the estimate of effect).</LI>
<LI>High risk of bias (no blinding or incomplete blinding, and the outcome or the outcome measurement is likely to be influenced by lack of blinding).</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Incomplete outcome data</HEADING>
<UL>
<LI>Low risk of bias (the underlying reasons for missingness are unlikely to make treatment effects departure from plausible values, or proper methods have been employed to handle missing data).</LI>
<LI>Uncertain risk of bias (there is insufficient information to assess whether the missing data mechanism in combination with the method used to handle missing data is likely to induce bias on the estimate of effect).</LI>
<LI>High risk of bias (the crude estimate of effects (eg, complete case estimate) will clearly be biased due to the underlying reasons for missingness, and the methods used to handle missing data are unsatisfactory).</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Selective outcome reporting</HEADING>
<UL>
<LI>Low risk of bias (the trial protocol is available and all of the trial's pre-specified outcomes that are of interest in the review have been reported or similar; if the trial protocol is not available, all the primary outcomes in this review are reported).</LI>
<LI>Uncertain risk of bias (there is insufficient information to assess whether the magnitude and direction of the observed effect is related to selective outcome reporting).</LI>
<LI>High risk of bias (not all of the trial's pre-specified primary outcomes have been reported or similar).</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Academic bias</HEADING>
<UL>
<LI>Low risk of bias (the author of the trial has not conducted previous trials addressing the same interventions).</LI>
<LI>Uncertain risk of bias (It is not clear if the author has conducted previous trials addressing the same interventions).</LI>
<LI>High risk of bias (the author of the trial has conducted previous trials addressing the same interventions).</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Vested interest bias</HEADING>
<UL>
<LI>Low risk of bias (the trial's source(s) of funding did not come from any parties that might have conflicting interest (eg, three dimensional laparoscope manufacturer).</LI>
<LI>Uncertain risk of bias (the source of funding was not clear).</LI>
<LI>High risk of bias (the trial was funded by a three dimensional laparoscope manufacturer).</LI>
</UL>
<P>We considered the trials that were classified as low risk of bias in all the above domains as trials with low risk of bias. All other trials were considered trials with high risk of bias.</P>
</SUBSECTION>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2010-12-07 09:04:55 +0100" MODIFIED_BY="Dimitrinka Nikolova">
<P>For dichotomous variables, we planned to calculate the risk ratio (RR) with 95% confidence interval (CI). Risk ratio calculations do not include trials in which no events occurred in either arm, whereas risk difference calculations do. We planned to report the risk difference if the results using this association measure were different from risk ratio. However, we did not find any such outcome. For continuous variables, we calculated the mean difference (MD) with 95% CI for operating time and standardised mean difference (SMD) with 95% CI for surgeons' satisfaction (where different scales might be used).</P>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2010-05-22 08:32:07 +0200" MODIFIED_BY="Kurinchi S Gurusamy">
<P>The unit of analysis was the individual patient who underwent laparoscopic cholecystectomy by three dimensional or two dimensional system.</P>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2010-07-09 11:34:05 +0200" MODIFIED_BY="Kurinchi S Gurusamy">
<P>We performed an intention-to-treat analysis (<LINK REF="REF-Newell-1992" TYPE="REFERENCE">Newell 1992</LINK>). We had planned to impute data for binary outcomes using various scenarios such as good outcome analysis, bad outcome analysis, best-case scenario, and worst-case scenario (<LINK REF="REF-Gurusamy-2009" TYPE="REFERENCE">Gurusamy 2009</LINK>; <LINK REF="REF-Gluud-2010" TYPE="REFERENCE">Gluud 2010</LINK>) and to use available-case analysis for continuous outcomes, should there have been more than one trial included.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2010-07-09 11:34:05 +0200" MODIFIED_BY="Kurinchi S Gurusamy">
<P>We had planned to explore heterogeneity by chi-squared test with significance set at P value 0.10, and measure the quantity of heterogeneity by I<SUP>2</SUP> should there have been more than one trial included (<LINK REF="REF-Higgins-2002" TYPE="REFERENCE">Higgins 2002</LINK>).</P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2010-07-09 11:34:05 +0200" MODIFIED_BY="Kurinchi S Gurusamy">
<P>We had planned to use visual asymmetry on a funnel plot to explore reporting bias (<LINK REF="REF-Egger-1997" TYPE="REFERENCE">Egger 1997</LINK>; <LINK REF="REF-Macaskill-2001" TYPE="REFERENCE">Macaskill 2001</LINK>). We had planned to perform linear regression approach described by <LINK REF="REF-Egger-1997" TYPE="REFERENCE">Egger 1997</LINK> to determine the funnel plot asymmetry. We did not perform these because of the presence of only one trial in this review.</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2010-12-03 11:06:53 +0100" MODIFIED_BY="Dimitrinka Nikolova">
<P>We had planned to perform the meta-analyses using the software package RevMan 5.0 (<LINK REF="REF-RevMan-2008" TYPE="REFERENCE">RevMan 2008</LINK>) and following the recommendations of The Cochrane Collaboration (<LINK REF="REF-Higgins-2009" TYPE="REFERENCE">Higgins 2009</LINK>) and the <I>Cochrane Hepato-Biliary Group Module </I>(<LINK REF="REF-Gluud-2010" TYPE="REFERENCE">Gluud 2010</LINK>). Both a random-effects model (<LINK REF="REF-DerSimonian-1986" TYPE="REFERENCE">DerSimonian 1986</LINK>) and a fixed-effect model (<LINK REF="REF-DeMets-1987" TYPE="REFERENCE">DeMets 1987</LINK>) were to be used. In case of discrepancy between the two models we were to report both results; otherwise we had planned to report the results of the fixed-effect model.</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2010-12-06 16:38:07 +0100" MODIFIED_BY="Dimitrinka Nikolova">
<P>We could not perform the following subgroup analyses:<BR/>- Trials with low bias risk compared to trials with high bias risk.<BR/>- Elective compared to emergency laparoscopic cholecystectomy.<BR/>- Human assistants compared to robotic assistants.<BR/>- Different three dimensional systems.</P>
<P>We did not perform any subgroup analysis because of the presence of only one trial in this review.</P>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2010-07-09 11:34:05 +0200" MODIFIED_BY="Kurinchi S Gurusamy">
<P>In case we found 'zero-event' trials in statistically significant outcomes, we had planned to perform a sensitivity analysis with and without empirical continuity correction factors as suggested by Sweeting et al (<LINK REF="REF-Sweeting-2004" TYPE="REFERENCE">Sweeting 2004</LINK>). However, there were no such outcomes.</P>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2010-12-07 09:22:52 +0100" MODIFIED_BY="Dimitrinka Nikolova">
<STUDY_DESCRIPTION MODIFIED="2010-12-07 09:22:52 +0100" MODIFIED_BY="Dimitrinka Nikolova">
<SEARCH_RESULTS MODIFIED="2010-12-07 09:22:52 +0100" MODIFIED_BY="Dimitrinka Nikolova">
<P>We identified a total of 181 references through the electronic searches of <I>The Cochrane Hepato-Biliary Group Controlled Trials Register</I> and <I>The Cochrane Central Register of Controlled Trials</I> (<I>CENTRAL</I>) in <I>The Cochrane Library</I> (n = 15), <I>MEDLINE</I> (n = 37), <I>EMBASE</I> (n = 78), <I>Science Citation Index Expanded</I> (n = 41), and meta-register of controlled trials (n = 10). We excluded 45 duplicates and 135 clearly irrelevant references through reading abstracts. One reference was retrieved for further assessment. This reference was a randomised clinical trial, which was suitable for inclusion in this review (<LINK REF="STD-Hanna-1998" TYPE="STUDY">Hanna 1998</LINK>). No reference was identified through scanning reference lists of the identified randomised trial. Despite the broad search strategy, there were no other randomised trials or quasi-randomised studies among the 180 references that we could list under the table &#8216;Characteristics of excluded studies&#8217;. The reference flow is shown in <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>.</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2010-07-09 11:34:05 +0200" MODIFIED_BY="Kurinchi S Gurusamy">
<P>The details of the population characteristics and the intervention in the only trial included in this review are shown in the table &#8216;Characteristics of included studies&#8217; (<LINK REF="STD-Hanna-1998" TYPE="STUDY">Hanna 1998</LINK>). This trial included patients undergoing elective laparoscopic cholecystectomy.</P>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2010-05-22 10:08:39 +0200" MODIFIED_BY="Kurinchi S Gurusamy">
<P>It was clear from reading the titles and abstracts of the remaining references retrieved from the search that there were no further randomised clinical trials or quasi-randomised studies.</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2010-12-07 09:22:32 +0100" MODIFIED_BY="Dimitrinka Nikolova">
<P>The risk of bias in the included trial is summarised in <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>.</P>
<ALLOCATION MODIFIED="2010-05-22 10:09:36 +0200" MODIFIED_BY="Kurinchi S Gurusamy">
<P>The sequence generation was adequate. The allocation concealment was unclear.</P>
</ALLOCATION>
<BLINDING MODIFIED="2010-07-09 11:34:05 +0200" MODIFIED_BY="Kurinchi S Gurusamy">
<P>It is impossible to blind the operating surgeons. There were no attempts at blinding the participants or outcome assessors.</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2010-05-22 10:14:59 +0200" MODIFIED_BY="Kurinchi S Gurusamy">
<P>There were no post-randomisation drop-outs. So, there was no bias related to incomplete outcome data.</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2010-07-09 11:34:05 +0200" MODIFIED_BY="Kurinchi S Gurusamy">
<P>We could not identify any protocol for the trial. The trial reported the important outcomes clearly and was not subjected to selective outcome reporting.</P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2010-12-06 16:11:22 +0100" MODIFIED_BY="Dimitrinka Nikolova">
<P>There was no baseline imbalance. The sample size was not reported, and hence, we were unable to determine if the trial was stopped early. There were no previous trials by the authors testing the same comparison. The trial was funded by a Government source, and we do not consider that the trial results are subjected to source of vested interest bias.</P>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2010-12-06 16:38:07 +0100" MODIFIED_BY="Dimitrinka Nikolova">
<SUBSECTION>
<HEADING LEVEL="3">Primary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Mortality</HEADING>
<P>There were no post-operative deaths in any of the intervention groups.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Adverse events</HEADING>
<P>There were no post-operative complications in any of the intervention groups.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Quality of life</HEADING>
<P>Quality of life measure of the patients were not reported in this trial.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Secondary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Conversion to open cholecystectomy</HEADING>
<P>There was no conversion to open cholecystectomy in either group.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Operating time</HEADING>
<P>There was no significant difference in the operating time between the two groups (MD -1.00 minute; 95% CI -17.77 to 15.77).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Errors</HEADING>
<P>Errors were defined as injuries to the gallbladder, liver, or diaphragm. There were six errors in each group. Since it was not clear whether more than one error occurred in one of the patients, it was not possible to perform statistical analysis on this outcome.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Surgeon satisfaction</HEADING>
<P>This was reported as visual strain and headache for the surgeons. The authors report that the visual strain and headache were higher in the three dimensional group, but they do not state the statistical significance.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Subgroup analysis</HEADING>
<P>This was not carried out because of the presence of only one trial in the review.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Statistical variation</HEADING>
<P>We did not perform the fixed-effect model meta-analyses nor the random-effects model analyses because of the presence of only one trial in the review. We did not report the risk difference since this did not alter the results of conversion to open cholecystectomy.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Funnel plot</HEADING>
<P>We did not explore reporting bias by funnel plot because of the presence of only one trial in the review.</P>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2010-12-06 16:38:07 +0100" MODIFIED_BY="Dimitrinka Nikolova">
<SUMMARY_OF_RESULTS MODIFIED="2010-12-06 16:38:07 +0100" MODIFIED_BY="Dimitrinka Nikolova">
<P>The only trial that compared three dimensional image with two dimensional imaging in laparoscopic cholecystectomy reported there were no death events and no patient had to be converted to open cholecystectomy. The trial analyses of data on other post-operative complications, operating time, and number of errors did not show any statistically meaningful differences between the two groups. Thus, currently, there is no evidence to prefer or reject three dimensional imaging over the traditional two dimensional imaging. Considering that most laparoscopic units have two dimensional imaging systems, implementation of three dimensional imaging will incur additional costs without any proven added benefits. Thus, there is no need at present for any change in the currently used two dimensional imaging.</P>
<P>Given the low proportion of complications in patients with laparoscopic cholecystectomy, it is unlikely that any trial will be powered to measure differences in complications between three dimensional and two dimensional systems. It is more likely that trials are powered to measure differences in the ease with which a surgeon operates and the stress caused by the system to the surgeon (by removing the necessity for the surgeon to mentally transform the two dimensional image into a three dimensional image using motion parallax through movement of the laparoscope, relative position of instruments, and shading of light and dark (<LINK REF="REF-Byrn-2007" TYPE="REFERENCE">Byrn 2007</LINK>)). Currently there is no validated measure of surgeon satisfaction. The development and validation of the measure is likely to involve surveys. Considering the considerable costs involved in conducting a randomised clinical trial, a validated measure of surgeon satisfaction seems necessary before further trials are conducted. </P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2010-07-09 11:34:05 +0200" MODIFIED_BY="Kurinchi S Gurusamy">
<P>This evidence is applicable to elective laparoscopic cholecystectomy only and not to other surgeries, which have other demands and require different decision-making skills.</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2010-12-06 16:38:07 +0100" MODIFIED_BY="Dimitrinka Nikolova">
<P>The only trial included in this review did not report blinding of patients or outcome assessors. This could introduce bias in all the outcomes reported in this review. Patient blinding can be achieved easily, and outcome assessor blinding can be achieved by using a second surgical team to monitor for post-operative complications or by evaluation of errors. To minimise bias one could employ blinded observers to administer questionnaires of surgeon satisfaction.</P>
<P>With new improvements in the technology and the method of production of three dimensional image (as explained in the 'Background' of the review), further randomised clinical trials are necessary to evaluate three dimensional imaging in laparoscopic cholecystectomy. Such trials should be adequately powered and should be conducted and reported according to the revised CONSORT Statement (<LINK REF="REF-Moher-2010" TYPE="REFERENCE">Moher 2010</LINK>).</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2010-07-13 18:09:36 +0200" MODIFIED_BY="Dimitrinka Nikolova">
<P>Only one trial was included in this review. There was no significant differences between the two groups in any of the outcomes. The review is subject to type II errors. Therefore, absence of evidence for a difference should not be taken as evidence of absence of a difference.</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2010-07-09 11:34:06 +0200" MODIFIED_BY="Kurinchi S Gurusamy">
<P>There has been no systematic review on this topic. As no meta-analyses could be performed, the review agrees with the conclusions of the only trial included in the review so far (<LINK REF="STD-Hanna-1998" TYPE="STUDY">Hanna 1998</LINK>). However, the risk of bias as well as random errors is judged to be high, which questions the validity of the included trial results.</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2010-11-18 13:12:27 +0100" MODIFIED_BY="Dimitrinka Nikolova">
<IMPLICATIONS_PRACTICE MODIFIED="2010-07-09 11:34:06 +0200" MODIFIED_BY="Kurinchi S Gurusamy">
<P>Currently, there is no evidence that three dimensional image is superior or inferior to two dimensional image in laparoscopic cholecystectomy.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2010-11-18 13:12:27 +0100" MODIFIED_BY="Dimitrinka Nikolova">
<P>A validated measure of surgeon satisfaction from the surgery is necessary to be established before further randomised clinical trials are conducted to assess the benefits and harms of three dimensional imaging compared with two dimensional imaging in laparoscopic cholecystectomy.</P>
<P>Future trials need to be conducted and reported according to the CONSORT Statement (<LINK REF="REF-Moher-2010" TYPE="REFERENCE">Moher 2010</LINK>).</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2010-11-18 13:12:32 +0100" MODIFIED_BY="Dimitrinka Nikolova">
<P>To Martyn Parker, author of more than 15 Cochrane reviews, who inspired the first author to prepare Cochrane reviews.<BR/>To Marwan Farouk, who taught the first author laparoscopic cholecystectomy.<BR/>To The Cochrane Hepato-Biliary Group for the support that they have provided.</P>
<P>Protocol<BR/>Peer Reviewers: Philip Rosenthal, USA; Steven M. Rudich, USA.<BR/>Contact Editor: Christian Gluud, Denmark.</P>
<P>Review<BR/>Peer Reviewers: Luit Penninga, Denmark; Martin Lund, Denmark.<BR/>Contact Editor: Christian Gluud, Denmark.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P>None known.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2010-07-09 11:34:06 +0200" MODIFIED_BY="Kurinchi S Gurusamy">
<P>KS Gurusamy prepared the review, and assessed the trials for inclusion and extracted data on included trials. S Sahay is the co-author of the protocol, and independently assessed the trials for inclusion and extracted data on included trials. BR Davidson critically commented on the review and provided advice for improving the review.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2010-12-06 16:38:07 +0100" MODIFIED_BY="Dimitrinka Nikolova">
<OL>
<LI>The outcomes were classified into primary and secondary outcomes. Quality of life was added to the primary outcomes according to recommendations in The Cochrane Handbook (<LINK REF="REF-Higgins-2009" TYPE="REFERENCE">Higgins 2009</LINK>). 'Conversion to open cholecystectomy' was added as an additional secondary outcome. We hypothesised that three dimensional imaging can improve the image quality, the information provided to the surgeons, and may avoid the need to convert to open cholecystectomy.</LI>
<LI>The methods used for assessment of the risk of bias were revised according to the updated version of the Cochrane Handbook (<LINK REF="REF-Higgins-2009" TYPE="REFERENCE">Higgins 2009</LINK>) and The Cochrane Hepato-Biliary Group Module (<LINK REF="REF-Gluud-2010" TYPE="REFERENCE">Gluud 2010</LINK>).</LI>
</OL>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2010-11-18 17:02:58 +0100" MODIFIED_BY="Kurinchi S Gurusamy">
<STUDIES MODIFIED="2010-05-22 07:09:10 +0200" MODIFIED_BY="Kurinchi S Gurusamy">
<INCLUDED_STUDIES MODIFIED="2010-05-22 07:09:10 +0200" MODIFIED_BY="Kurinchi S Gurusamy">
<STUDY DATA_SOURCE="PUB" ID="STD-Hanna-1998" MODIFIED="2010-05-22 07:09:10 +0200" MODIFIED_BY="Kurinchi S Gurusamy" NAME="Hanna 1998" YEAR="1998">
<REFERENCE MODIFIED="2010-05-22 07:09:10 +0200" MODIFIED_BY="Kurinchi S Gurusamy" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hanna GB, Shimi SM, Cuschieri A</AU>
<TI>Randomised study of influence of two-dimensional versus three-dimensional imaging on performance of laparoscopic cholecystectomy</TI>
<SO>Lancet</SO>
<YR>1998</YR>
<VL>351</VL>
<NO>9098</NO>
<PG>248-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES/>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2010-11-18 17:02:58 +0100" MODIFIED_BY="Kurinchi S Gurusamy">
<ADDITIONAL_REFERENCES MODIFIED="2010-11-18 17:02:58 +0100" MODIFIED_BY="Kurinchi S Gurusamy">
<REFERENCE ID="REF-Bakken-2004" MODIFIED="2008-11-05 14:24:16 +0100" MODIFIED_BY="Sarah Louise Klingenberg" NAME="Bakken 2004" TYPE="JOURNAL_ARTICLE">
<AU>Bakken IJ, Skjeldestad FE, Mjåland O, Johnson E</AU>
<TI>Cholecystectomy in Norway 1990-2002</TI>
<TO>Kolecystektomi i Norge i 1990-2002</TO>
<SO>Tidsskrift for den Norske Laegeforening</SO>
<YR>2004</YR>
<VL>124</VL>
<NO>18</NO>
<PG>2376-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Byrn-2007" MODIFIED="2008-11-05 14:24:16 +0100" MODIFIED_BY="Sarah Louise Klingenberg" NAME="Byrn 2007" TYPE="JOURNAL_ARTICLE">
<AU>Byrn JC, Schluender S, Divino CM, Conrad J, Gurland B, Shlasko E, et al</AU>
<TI>Three-dimensional imaging improves surgical performance for both novice and experienced operators using the da Vinci Robot System</TI>
<SO>American Journal of Surgery</SO>
<YR>2007</YR>
<VL>193</VL>
<NO>4</NO>
<PG>519-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-DeMets-1987" MODIFIED="2008-11-05 14:24:16 +0100" MODIFIED_BY="Sarah Louise Klingenberg" NAME="DeMets 1987" TYPE="JOURNAL_ARTICLE">
<AU>DeMets DL</AU>
<TI>Methods for combining randomized clinical trials: strengths and limitations</TI>
<SO>Statistics in Medicine</SO>
<YR>1987</YR>
<VL>6</VL>
<NO>3</NO>
<PG>341-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-DerSimonian-1986" MODIFIED="2008-11-05 14:24:16 +0100" MODIFIED_BY="Sarah Louise Klingenberg" NAME="DerSimonian 1986" TYPE="JOURNAL_ARTICLE">
<AU>DerSimonian R, Laird N</AU>
<TI>Meta-analysis in clinical trials</TI>
<SO>Controlled Clinical Trials</SO>
<YR>1986</YR>
<VL>7</VL>
<NO>3</NO>
<PG>177-88</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Egger-1997" MODIFIED="2008-11-05 14:24:16 +0100" MODIFIED_BY="Sarah Louise Klingenberg" NAME="Egger 1997" TYPE="JOURNAL_ARTICLE">
<AU>Egger M, Davey SG, Schneider M, Minder C</AU>
<TI>Bias in meta-analysis detected by a simple, graphical test</TI>
<SO>BMJ (Clinical Research Ed.)</SO>
<YR>1997</YR>
<VL>315</VL>
<NO>7109</NO>
<PG>629-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Fullarton-1994" MODIFIED="2008-11-05 14:24:16 +0100" MODIFIED_BY="Sarah Louise Klingenberg" NAME="Fullarton 1994" TYPE="JOURNAL_ARTICLE">
<AU>Fullarton GM, Bell G</AU>
<TI>Prospective audit of the introduction of laparoscopic cholecystectomy in the west of Scotland. West of Scotland Laparoscopic Cholecystectomy Audit Group</TI>
<SO>Gut</SO>
<YR>1994</YR>
<VL>35</VL>
<NO>8</NO>
<PG>1121-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gluud-2010" MODIFIED="2010-11-04 14:56:01 +0100" MODIFIED_BY="[Empty name]" NAME="Gluud 2010" TYPE="OTHER">
<AU>Gluud C, Nikolova D, Klingenberg SL, Alexakis N, Als-Nielsen B, Colli A, et al</AU>
<TI>Cochrane Hepato-Biliary Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs))</TI>
<SO>2010, Issue 10. Art. No.: LIVER</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gurusamy-2009" MODIFIED="2010-05-22 08:38:31 +0200" MODIFIED_BY="Kurinchi S Gurusamy" NAME="Gurusamy 2009" TYPE="JOURNAL_ARTICLE">
<AU>Gurusamy KS, Gluud C, Nikolova D, Davidson BR</AU>
<TI>Assessment of risk of bias in randomized clinical trials in surgery</TI>
<SO>The British Journal of Surgery</SO>
<YR>2009</YR>
<VL>96</VL>
<NO>4</NO>
<PG>342-9</PG>
<IDENTIFIERS MODIFIED="2010-05-22 08:38:31 +0200" MODIFIED_BY="Kurinchi S Gurusamy"/>
</REFERENCE>
<REFERENCE ID="REF-Halldestam-2004" MODIFIED="2010-11-04 14:56:23 +0100" MODIFIED_BY="[Empty name]" NAME="Halldestam 2004" TYPE="JOURNAL_ARTICLE">
<AU>Halldestam I, Enell EL, Kullman E, Borch K</AU>
<TI>Development of symptoms and complications in individuals with asymptomatic gallstones</TI>
<SO>The British Journal of Surgery</SO>
<YR>2004</YR>
<VL>91</VL>
<NO>6</NO>
<PG>734-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hanna-1998" MODIFIED="2008-11-05 14:24:16 +0100" MODIFIED_BY="Sarah Louise Klingenberg" NAME="Hanna 1998" TYPE="JOURNAL_ARTICLE">
<AU>Hanna GB, Shimi SM, Cuschieri A</AU>
<TI>Randomised study of influence of two-dimensional versus three-dimensional imaging on performance of laparoscopic cholecystectomy</TI>
<SO>Lancet</SO>
<YR>1998</YR>
<VL>351</VL>
<NO>9098</NO>
<PG>248-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-HES-2005" MODIFIED="2010-11-04 14:57:13 +0100" MODIFIED_BY="[Empty name]" NAME="HES 2005" TYPE="OTHER">
<AU>Hospital Episode Statistics</AU>
<TI>Main operations. 3 character: 2004-05</TI>
<SO>http://www.hesonline.nhs.uk/Ease/servlet/ContentServer?siteID=1937&amp;categoryID=205</SO>
<YR>(accessed 4 November 2010)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2002" MODIFIED="2008-11-05 14:24:16 +0100" MODIFIED_BY="Sarah Louise Klingenberg" NAME="Higgins 2002" TYPE="JOURNAL_ARTICLE">
<AU>Higgins JPT, Thompson SG</AU>
<TI>Quantifying heterogeneity in a meta-analysis</TI>
<SO>Statistics in Medicine</SO>
<YR>2002</YR>
<VL>21</VL>
<NO>11</NO>
<PG>1539-58</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2009" MODIFIED="2010-11-04 14:57:38 +0100" MODIFIED_BY="[Empty name]" NAME="Higgins 2009" TYPE="OTHER">
<AU>Higgins JPT, Green S (editors)</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]</TI>
<SO>The Cochrane Colloboration, 2009. Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-J_x00f8_rgensen-1987" MODIFIED="2008-11-05 14:24:16 +0100" MODIFIED_BY="Sarah Louise Klingenberg" NAME="Jørgensen 1987" TYPE="JOURNAL_ARTICLE">
<AU>Jørgensen T</AU>
<TI>Prevalence of gallstones in a Danish population</TI>
<SO>American Journal of Epidemiology</SO>
<YR>1987</YR>
<VL>126</VL>
<NO>5</NO>
<PG>912-21</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Keus-2006" MODIFIED="2010-11-18 16:57:18 +0100" MODIFIED_BY="Kurinchi S Gurusamy" NAME="Keus 2006" TYPE="COCHRANE_REVIEW">
<AU>Keus F, de Jong JA, Gooszen HG, van Laarhoven CJ</AU>
<TI>Laparoscopic versus open cholecystectomy for patients with symptomatic cholecystolithiasis</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2006</YR>
<NO>4</NO>
<PG>CD006231</PG>
<IDENTIFIERS MODIFIED="2010-11-18 16:57:18 +0100" MODIFIED_BY="Kurinchi S Gurusamy">
<IDENTIFIER MODIFIED="2010-11-18 16:57:18 +0100" MODIFIED_BY="Kurinchi S Gurusamy" TYPE="DOI" VALUE="10.1002/14651858"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Keus-2010" MODIFIED="2010-11-18 16:55:42 +0100" MODIFIED_BY="Kurinchi S Gurusamy" NAME="Keus 2010" TYPE="COCHRANE_REVIEW">
<AU>Keus F, Gooszen HG, van Laarhoven CJ</AU>
<TI>Open, small-incision, or laparoscopic cholecystectomy for patients with symptomatic cholecystolithiasis. An overview of Cochrane Hepato-Biliary Group reviews</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2010</YR>
<NO>1</NO>
<PG>CD008318</PG>
<IDENTIFIERS MODIFIED="2010-11-18 16:55:42 +0100" MODIFIED_BY="Kurinchi S Gurusamy">
<IDENTIFIER MODIFIED="2010-11-18 16:55:42 +0100" MODIFIED_BY="Kurinchi S Gurusamy" TYPE="DOI" VALUE="10.1002/14651858"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Kjaergard-2001" MODIFIED="2008-11-05 14:24:16 +0100" MODIFIED_BY="Sarah Louise Klingenberg" NAME="Kjaergard 2001" TYPE="JOURNAL_ARTICLE">
<AU>Kjaergard LL, Villumsen J, Gluud C</AU>
<TI>Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses</TI>
<SO>Annals of Internal Medicine</SO>
<YR>2001</YR>
<VL>135</VL>
<NO>11</NO>
<PG>982-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Macaskill-2001" MODIFIED="2008-11-05 14:24:16 +0100" MODIFIED_BY="Sarah Louise Klingenberg" NAME="Macaskill 2001" TYPE="JOURNAL_ARTICLE">
<AU>Macaskill P, Walter SD, Irwig L</AU>
<TI>A comparison of methods to detect publication bias in meta-analysis</TI>
<SO>Statistics in Medicine</SO>
<YR>2001</YR>
<VL>20</VL>
<NO>4</NO>
<PG>641-54</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mj_x00e4_land-1998" MODIFIED="2008-11-05 14:24:16 +0100" MODIFIED_BY="Sarah Louise Klingenberg" NAME="Mjäland 1998" TYPE="JOURNAL_ARTICLE">
<AU>Mjäland O, Adamsen S, Hjelmquist B, Ovaska J, Buanes T</AU>
<TI>Cholecystectomy rates, gallstone prevalence, and handling of bile duct injuries in Scandinavia. A comparative audit</TI>
<SO>Surgical Endoscopy</SO>
<YR>1998</YR>
<VL>12</VL>
<NO>12</NO>
<PG>1386-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Moher-1998" MODIFIED="2008-11-05 14:24:16 +0100" MODIFIED_BY="Sarah Louise Klingenberg" NAME="Moher 1998" TYPE="JOURNAL_ARTICLE">
<AU>Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al</AU>
<TI>Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?</TI>
<SO>Lancet</SO>
<YR>1998</YR>
<VL>352</VL>
<NO>9128</NO>
<PG>609-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Moher-2010" MODIFIED="2010-11-04 14:58:21 +0100" MODIFIED_BY="[Empty name]" NAME="Moher 2010" TYPE="JOURNAL_ARTICLE">
<AU>Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ, et al</AU>
<TI>CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials</TI>
<SO>BMJ (Clinical Research Ed.)</SO>
<YR>2010</YR>
<VL>340</VL>
<PG>c869</PG>
<IDENTIFIERS MODIFIED="2010-05-22 17:53:40 +0200" MODIFIED_BY="Kurinchi S Gurusamy"/>
</REFERENCE>
<REFERENCE ID="REF-Muhrbeck-1995" MODIFIED="2008-11-05 14:24:16 +0100" MODIFIED_BY="Sarah Louise Klingenberg" NAME="Muhrbeck 1995" TYPE="JOURNAL_ARTICLE">
<AU>Muhrbeck O, Ahlberg J</AU>
<TI>Prevalence of gallstone disease in a Swedish population</TI>
<SO>Scandinavian Journal of Gastroenterology</SO>
<YR>1995</YR>
<VL>30</VL>
<NO>11</NO>
<PG>1125-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Newell-1992" MODIFIED="2008-11-05 14:24:16 +0100" MODIFIED_BY="Sarah Louise Klingenberg" NAME="Newell 1992" TYPE="JOURNAL_ARTICLE">
<AU>Newell DJ</AU>
<TI>Intention-to-treat analysis: implications for quantitative and qualitative research</TI>
<SO>International Journal of Epidemiology</SO>
<YR>1992</YR>
<VL>21</VL>
<NO>5</NO>
<PG>837-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Parker-2007" MODIFIED="2008-11-05 14:24:16 +0100" MODIFIED_BY="Sarah Louise Klingenberg" NAME="Parker 2007" TYPE="JOURNAL_ARTICLE">
<AU>Parker AJ</AU>
<TI>Binocular depth perception and the cerebral cortex</TI>
<SO>Nature reviews. Neuroscience</SO>
<YR>2007</YR>
<VL>8</VL>
<NO>5</NO>
<PG>379-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-RevMan-2008" MODIFIED="2008-11-05 14:24:16 +0100" MODIFIED_BY="Sarah Louise Klingenberg" NAME="RevMan 2008" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2008</YR>
<EN>5.0</EN>
<PB>The Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<CY>Copenhagen</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Royle-2003" MODIFIED="2010-05-22 08:48:07 +0200" MODIFIED_BY="Kurinchi S Gurusamy" NAME="Royle 2003" TYPE="JOURNAL_ARTICLE">
<AU>Royle P, Milne R</AU>
<TI>Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches</TI>
<SO>International Journal of Technology Assessment in Health Care</SO>
<YR>2003</YR>
<VL>19</VL>
<NO>4</NO>
<PG>591-603</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Schulz-1995" MODIFIED="2008-11-05 14:24:16 +0100" MODIFIED_BY="Sarah Louise Klingenberg" NAME="Schulz 1995" TYPE="JOURNAL_ARTICLE">
<AU>Schulz KF, Chalmers I, Hayes RJ, Altman DG</AU>
<TI>Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials</TI>
<SO>JAMA</SO>
<YR>1995</YR>
<VL>273</VL>
<NO>5</NO>
<PG>408-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sweeting-2004" MODIFIED="2008-11-05 14:24:16 +0100" MODIFIED_BY="Sarah Louise Klingenberg" NAME="Sweeting 2004" TYPE="JOURNAL_ARTICLE">
<AU>Sweeting MJ, Sutton AJ, Lambert PC</AU>
<TI>What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data</TI>
<SO>Statistics in Medicine</SO>
<YR>2004</YR>
<VL>23</VL>
<NO>9</NO>
<PG>1351-75</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wood-2008" MODIFIED="2008-11-05 14:24:16 +0100" MODIFIED_BY="Sarah Louise Klingenberg" NAME="Wood 2008" TYPE="JOURNAL_ARTICLE">
<AU>Wood L, Egger M, Gluud LL, Schulz KF, Jüni P, Altman GD, et al</AU>
<TI>Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study</TI>
<SO>BMJ (Clinical Research Ed.)</SO>
<YR>2008</YR>
<VL>336</VL>
<PG>601-5</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2010-12-06 16:16:31 +0100" MODIFIED_BY="Dimitrinka Nikolova">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2010-12-06 16:16:31 +0100" MODIFIED_BY="Dimitrinka Nikolova" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2010-07-09 11:34:06 +0200" MODIFIED_BY="Kurinchi S Gurusamy" STUDY_ID="STD-Hanna-1998">
<CHAR_METHODS MODIFIED="2010-05-22 07:09:51 +0200" MODIFIED_BY="Kurinchi S Gurusamy">
<P>Randomised clinical trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-06-21 16:59:30 +0200" MODIFIED_BY="Dimitrinka Nikolova">
<P>Country: United Kingdom.<BR/>Year of study: not stated.<BR/>Number randomised: 60.<BR/>Post-randomisation drop-out: 0 (0%).<BR/>Median age: 58 years (group 1); 52 years (group 2).<BR/>Age range: 27 to 87 years.<BR/>Females: 45 (75%).<BR/>Acute cholecystitis: 0 (0%).</P>
<P>Inclusion criteria</P>
<OL>
<LI>Symptomatic gallstones.</LI>
<LI>Elective cholecystectomy.</LI>
</OL>
<P>Exclusion criteria</P>
<OL>
<LI>Previous upper abdominal surgery.</LI>
</OL>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-07-09 11:34:06 +0200" MODIFIED_BY="Kurinchi S Gurusamy">
<P>Participants were randomly assigned to two groups.</P>
<P>Group 1: three dimensional imaging (n = 30).</P>
<P>Group 2: two dimensional imaging (n = 30).</P>
<P>Mechanism of three dimensional image: sequential imaging, alternating between the two eyes by means of optical shutters thus presenting two slightly different images in an alternating sequence to each of the eyes separated by a few milliseconds.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-05-22 10:12:45 +0200" MODIFIED_BY="Kurinchi S Gurusamy">
<OL>
<LI>Post-operative complications.</LI>
<LI>Conversion to open cholecystectomy.</LI>
<LI>Operating time.</LI>
<LI>Errors.</LI>
<LI>Image quality.</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-05-28 09:55:58 +0200" MODIFIED_BY="Kurinchi S Gurusamy">
<P>Attempts were made to contact the authors in May 2010. No replies were received.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES SORT_BY="STUDY">
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2010-12-06 16:16:31 +0100" MODIFIED_BY="Dimitrinka Nikolova">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2010-05-22 07:16:28 +0200" MODIFIED_BY="Kurinchi S Gurusamy" NO="1">
<NAME>Adequate sequence generation?</NAME>
<DESCRIPTION>
<P>Was the allocation sequence adequately generated?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-22 07:16:28 +0200" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="YES" STUDY_ID="STD-Hanna-1998">
<DESCRIPTION>
<P>Quote: "Randomisation was by random computer generated allocation list".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2010-07-13 18:11:06 +0200" MODIFIED_BY="Dimitrinka Nikolova" NO="2">
<NAME>Allocation concealment?</NAME>
<DESCRIPTION>
<P>Was allocation adequately concealed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-13 18:11:06 +0200" MODIFIED_BY="Dimitrinka Nikolova" RESULT="UNKNOWN" STUDY_ID="STD-Hanna-1998">
<DESCRIPTION>
<P>No information.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2010-07-13 18:11:11 +0200" MODIFIED_BY="Dimitrinka Nikolova" NO="3">
<NAME>Blinding?</NAME>
<DESCRIPTION>
<P>Was knowledge of the allocated interventions adequately prevented during the study?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-07-13 18:11:11 +0200" MODIFIED_BY="Dimitrinka Nikolova" RESULT="NO" STUDY_ID="STD-Hanna-1998">
<DESCRIPTION>
<P>No blinding.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2010-05-22 07:17:11 +0200" MODIFIED_BY="Kurinchi S Gurusamy" NO="4">
<NAME>Incomplete outcome data addressed?</NAME>
<DESCRIPTION>
<P>Were incomplete outcome data adequately addressed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-05-22 07:17:11 +0200" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="YES" STUDY_ID="STD-Hanna-1998">
<DESCRIPTION>
<P>Comment: There were no post-randomisation drop-outs.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2010-05-28 09:55:43 +0200" MODIFIED_BY="Kurinchi S Gurusamy" NO="5">
<NAME>Free of selective reporting?</NAME>
<DESCRIPTION>
<P>Are reports of the study free of suggestion of selective outcome reporting?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-28 09:55:43 +0200" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="YES" STUDY_ID="STD-Hanna-1998">
<DESCRIPTION>
<P>Comment: The primary outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Free of other bias?</NAME>
<DESCRIPTION>
<P>Was the study apparently free of other problems that could put it at a high risk of bias?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="STUDY" MODIFIED="2010-12-06 16:16:31 +0100" MODIFIED_BY="Dimitrinka Nikolova" NO="7">
<NAME>Free of baseline imbalance bias?</NAME>
<DESCRIPTION/>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="STUDY" MODIFIED="2010-12-06 16:16:31 +0100" MODIFIED_BY="Dimitrinka Nikolova" NO="8">
<NAME>Free of early stopping bias?</NAME>
<DESCRIPTION/>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-09" LEVEL="STUDY" MODIFIED="2010-12-06 16:16:31 +0100" MODIFIED_BY="Dimitrinka Nikolova" NO="9">
<NAME>Free of academic bias?</NAME>
<DESCRIPTION/>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-22 07:18:25 +0200" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="YES" STUDY_ID="STD-Hanna-1998">
<DESCRIPTION>
<P>Comment: No previous similar trial by the same authors.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-10" LEVEL="STUDY" MODIFIED="2010-12-06 16:16:31 +0100" MODIFIED_BY="Dimitrinka Nikolova" NO="10">
<NAME>Free of vested interest bias?</NAME>
<DESCRIPTION/>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-22 07:19:59 +0200" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="YES" STUDY_ID="STD-Hanna-1998">
<DESCRIPTION>
<P>Quote: "This work was supported by a grant from Scottish Office'.</P>
<P>Comment: This trial was sponsored by an entity with no vested interest in the results.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES MODIFIED="2008-11-05 14:19:57 +0100" MODIFIED_BY="Sarah Louise Klingenberg"/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2010-05-22 10:37:23 +0200" MODIFIED_BY="Kurinchi S Gurusamy"/>
<FIGURES MODIFIED="2010-12-07 09:22:32 +0100" MODIFIED_BY="Dimitrinka Nikolova">
<FIGURE FILENAME="Prisma flow diagram.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2010-12-07 09:22:32 +0100" MODIFIED_BY="Dimitrinka Nikolova" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Reference flow</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAhsAAAIGCAIAAAByDdqvAABJfElEQVR42u2df5Ab1Z3g+1+XqVSo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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2010-12-07 09:22:32 +0100" MODIFIED_BY="Dimitrinka Nikolova" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Risk of bias summary: review authors' judgements about each risk of bias item for each included trial.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAS8AAAEICAIAAACBFeUBAAALtklEQVR42u3du24kVRDG8ZFICBw4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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2010-11-04 14:59:43 +0100" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2010-11-04 14:59:43 +0100" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2008-11-05 14:19:39 +0100" MODIFIED_BY="Sarah Louise Klingenberg">Search Strategies</TITLE>
<APPENDIX_BODY MODIFIED="2010-11-04 14:59:43 +0100" MODIFIED_BY="[Empty name]">
<TABLE COLS="3" ROWS="7">
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Database</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Period of Search</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Search Strategy</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>The Cochrane Hepato-Biliary Group Controlled Trials Register</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>October 2010</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>(laparoscop* OR coelioscop* OR celioscop* OR peritoneoscop*) AND (cholecystectom*) AND (two OR three) AND (dimension* OR imag*)<BR/>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Cochrane Central Register of Controlled Trials (CENTRAL) in The Cochrane Library (Wiley)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Issue 10, 2010</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>#1 (laparoscop* OR coelioscop* OR celioscop* OR peritoneoscop*) AND (cholecystectom*)<BR/>#2 MeSH descriptor Cholecystectomy, Laparoscopic explode all trees<BR/>#3 (#1 OR #2)<BR/>#4 (two OR three) AND (dimension* OR imag*)<BR/>#5 MeSH descriptor Image Processing, Computer-Assisted explode all trees<BR/>#6 MeSH descriptor Image Enhancement explode all trees<BR/>#7 MeSH descriptor Imaging, Three-Dimensional explode all trees<BR/>#8 (#4 OR #5 OR #6 OR #7)<BR/>#9 (#3 AND #8)<BR/>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>MEDLINE (Pubmed)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1987 to October 2010</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>(((laparoscop* OR coelioscop* OR celioscop* OR peritoneoscop*) AND (cholecystectom*)) OR "cholecystectomy, laparoscopic"[MeSH]) AND (((two OR three) AND (dimension* OR imag*)) OR "Image Processing, Computer-Assisted"[Mesh] OR "Image Enhancement"[Mesh] OR "Imaging, Three-Dimensional"[Mesh]) AND (((randomised controlled trial [pt] OR controlled clinical trial [pt] OR randomised controlled trials [mh] OR random allocation [mh] OR double-blind method [mh] OR single-blind method [mh] OR clinical trial [pt] OR clinical trials [mh] OR ("clinical trial" [tw]) OR ((singl* [tw] OR doubl* [tw] OR trebl* [tw] OR tripl* [tw]) AND (mask* [tw] OR blind* [tw])) OR (placebos [mh] OR placebo* [tw] OR random* [tw] OR research design [mh:noexp]) NOT (animals [mh] NOT human [mh]))))</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>EMBASE (OvidSP)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1987 to October 2010</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1 ((laparoscop* or coelioscop* or celioscop* or peritoneoscop*) and cholecystectom*).af.<BR/>2 exp laparoscopic surgery/ and exp cholecystectomy/ <BR/>3 1 or 2 <BR/>4 ((two or three) and (dimension* or imag*)).af. <BR/>5 exp three dimensional imaging/ <BR/>6 4 or 5 <BR/>7 random:.tw. or clinical trial:.mp. or exp health care quality/ <BR/>8 6 and 3 and 7<BR/>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Science Citation Index Expanded (http://apps.isiknowledge.com)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1987 to October 2010</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>#1 TS=((laparoscop* OR coelioscop* OR celioscop* OR peritoneoscop*) AND (cholecystectom*))<BR/>#2 TS=((two OR three) AND (dimension* OR imag*))<BR/>#3 TS=(random* or placebo* or blind* or meta-analysis)<BR/>#4 #3 AND #2 AND #1<BR/>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Meta-register of controlled trials (mRCT) (http://www.controlled-trials.com/mrct/)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>October 2010</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>(two OR three) AND (dimension* OR imag*) AND cholecystectom*</P>
</TD>
</TR>
</TABLE>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>